Two brain cancer treatments compared for lung cancer patients

This trial is testing whether combining bevacizumab—a medication that improves how tumors respond to radiation—with focused radiation therapy works better than a whole-brain radiation approach for people whose lung cancer has spread to many areas of the brain. The goal is to see if the medication helps control brain tumors more effectively while protecting memory and thinking skills. Researchers believe this combination could be a better option for patients with extensive brain cancer who cannot have surgery.

Current standard treatments for widespread brain metastases can slow down thinking and memory loss, and don't always control the cancer well enough. This trial exists to find out whether adding this medication to a more focused radiation approach can improve both cancer control and preserve brain function better than treating the whole brain.